DSOL (Drug Free Solution) EPS without NRI: $-0.01 (TTM As of Feb. 2014)


What is Drug Free Solution EPS without NRI?

Drug Free Solution DSOL EPS without NRI is $-0.01 as of Feb. 2014.

Drug Free Solution's earnings per share without non-recurring items for the three months ended in Feb. 2014 was $0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2014 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Drug Free Solution's EPS without NRI or its related term are showing as below:

DSOL's 3-Year EPS without NRI Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Drug Free Solution's EPS (Diluted) for the three months ended in Feb. 2014 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2014 was $-0.01.

Drug Free Solution's EPS (Basic) for the three months ended in Feb. 2014 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2014 was $-0.01.


Drug Free Solution  (OTCPK:DSOL) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Drug Free Solution EPS without NRI Related Terms


Drug Free Solution EPS without NRI Historical Data

* Premium members only.

The historical data trend for Drug Free Solution's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drug Free Solution EPS without NRI Chart

Drug Free Solution Annual Data
Trend May12 May13
EPS without NRI
-0.01 -0.01

Drug Free Solution Quarterly Data
Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 -0.01 0.00 0.00 0.00

DSOL vs USEL, ZZLL, WSCO: EPS without NRI Comparison

For the Health Information Services subindustry, Drug Free Solution's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Drug Free Solution PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Drug Free Solution's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Drug Free Solution's PE Ratio without NRI falls into.



Drug Free Solution EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-0.01 mean?
Drug Free Solution (DSOL) has a EPS without NRI of $-0.01 as of Feb. 2014. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Drug Free Solution and its competitors.
Is Drug Free Solution's EPS without NRI too high?
Drug Free Solution's current EPS without NRI is $-0.01.
How does Drug Free Solution's EPS without NRI compare to USEL and ZZLL?
Drug Free Solution's EPS without NRI of $-0.01 can be compared against companies in the Healthcare Providers & Services industry. The industry median EPS without NRI is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.00, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Drug Free Solution and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Drug Free Solution's current EPS without NRI is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drug Free Solution stock overvalued right now?
Drug Free Solution (DSOL) has a current EPS without NRI of $-0.01. The current EPS without NRI is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Drug Free Solution (DSOL), the current EPS without NRI is $-0.01 as of Feb. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drug Free Solution Business Description

Address 2211 Michelson Drive, Irvine, CA, USA, 92612
Drug Free Solution Inc is a United States based holding company that owns and operates various subsidiaries in the healthcare industry. It is focused on acquiring healthcare operations that focus on Home Healthcare, Developmental Disabilities, Hospice Care, Skilled Nursing, Residential Rehabilitation, Home & Community Based Services.